相关实验视频
Updated: May 7, 2025

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
Published on: June 2, 2022
C-反应蛋白与白蛋白比率和慢性阻塞性肺病之间的关联:一个横截面研究
Ting Ao1, Yingxiu Huang1, Peng Zhen1
1Department of Infectious Diseases, Beijing Luhe Hospital, Capital Medical University, No.82, Xinhua South Road, Tongzhou District, Beijing, 101100, China.
C-反应蛋白与白蛋白比率 (CAR) 与患慢性阻塞性肺病 (COPD) 的风险更高有关. 这项研究发现,较高的CAR水平与COPD患病率的增加相关,这突出了CAR作为潜在的生物标志物.
科学领域:
- 肺部医学 肺部医学
- 生物标志物 生物标志物
- 炎症标志物 炎症标志物
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重要的全球健康问题.
- C-反应蛋白与白蛋白比率 (CAR) 是各种疾病的新兴生物标志物.
- CAR和COPD之间的关联需要进一步调查.
研究的目的:
- 调查C反应蛋白与白蛋白比率 (CAR) 与慢性阻塞性肺病 (COPD) 的患病率之间的关系.
主要方法:
- 使用国家健康和营养检查调查数据 (1999-2010年) 进行的横截面研究.
- 基于自我报告的信息来识别COPD.
- 后勤回归分析以确定CAR和COPD关联的几率比率 (OR) 和95%置信区间 (CI).
- 为结果验证进行的子组和灵敏度分析.
主要成果:
- 该研究包括24,627名参与者,其中1,809人被诊断患有COPD.
- 调整后的分析显示,CAR和COPD之间存在显著的关联 (OR 1.37;95% CI,1.12-1.69;P=0.003).
- 与最低三分之一 (95% CI,1.17-1.65;P<0.001) 相比,最高CAR三分之一的个体患COPD的风险增加了1.39倍.
结论:
- 较高的C-反应蛋白与白蛋白比率 (CAR) 水平与慢性阻塞性肺病 (COPD) 的风险增加有显著的相关性.
- 汽车可以作为COPD的有价值的预测生物标志物.
更多相关视频
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...